E4orf1 limits the oncolytic potential of the E1B-55K deletion mutant adenovirus

Journal of Virology

Volumn 83, Issue 6, 2009, Pages 2406-2416

  Thomas, Michael A ^a   Broughton, Robin S ^b   Goodrum, Felicia D ^c   Ornelles, David A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b MEHARRY MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR TIAM1; MAMMALIAN TARGET OF RAPAMYCIN; ONCOLYTIC ADENOVIRUS; ONYX 015; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAC1 PROTEIN; S6 KINASE; UNCLASSIFIED DRUG; VIRUS PROTEIN; ONCOLYTIC VIRUS; ONCOPROTEIN; TIAM1 PROTEIN, HUMAN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CANCER THERAPY; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; E4ORF1 GENE; HUMAN; HUMAN CELL; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; VIRUS ONCOGENE; VIRUS REPLICATION; GENE DELETION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HELA CELL; HOST PATHOGEN INTERACTION; METABOLISM; PHOSPHORYLATION;

ADENOVIRIDAE;

ADENOVIRIDAE; GENE DELETION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; ONCOGENE PROTEIN V-AKT; ONCOGENE PROTEINS, VIRAL; ONCOLYTIC VIRUSES; PHOSPHORYLATION; RAC1 GTP-BINDING PROTEIN; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA;

EID: 62749128485     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01972-08     Document Type: Article

References (79)

1. Araujo, F. D., T. H. Stracker, C. T. Carson, D. V. Lee, and M. D. Weitzman. 2005. Adenovirus type 5 E4orf3 protein targets the Mre11 complex to cytoplasmic aggresomes. J. Virol. 79:11382-11391.
2. Babiss, L. E., and H. S. Ginsberg. 1984. Adenovirus type 5 early region 1b gene product is required for efficient shutoff of host protein synthesis. J. Virol. 50:202-212.
3. Baker, A., K. J. Rohleder, L. A. Hanakahi, and G. Ketner. 2007. Adenovirus E4 34k and E1b 55k oncoproteins target host DNA ligase IV for proteasomal degradation. J. Virol. 81:7034-7040.
4. Barker, D. D., and A. J. Berk. 1987. Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection. Virology 156:107-121.
5. Barraud, P., J. C. Paillart, R. Marquet, and C. Tisne. 2008. Advances in the structural understanding of Vif proteins. Curr. HIV Res. 6:91-99.
6. Berk, A. J. 2005. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 24:7673-7685.
7. Bischoff, J. R., D. H. Kirn, A. Williams, C. Heise, S. Horn, M. Muna, L. Ng, J. A. Nye, A. Sampson-Johannes, A. Fattaey, and F. McCormick. 1996. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274:373-376.
8. Blanchette, P., K. Kindsmuller, P. Groitl, F. Dallaire, T. Speiseder, P. E. Branton, and T. Dobner. 2008. Control of mRNA export by adenovirus E4orf6 and E1B55K proteins during productive infection requires E4orf6 ubiquitin ligase activity. J. Virol. 82:2642-2651.
9. Bridge, E., and G. Ketner. 1990. Interaction of adenoviral E4 and Elb products in late gene expression. Virology 174:345-353.
10. Bridge, E., S. Medghalchi, S. Ubol, M. Leesong, and G. Ketner. 1993. Adenovirus early region 4 and viral DNA synthesis. Virology 193:794-801.
11. Buchkovich, N. J., Y. Yu, C. A. Zampieri, and J. C. Alwine. 2008. The TORrid affairs of viruses: effects of mammalian DNA viruses on the PI3K-Akt-mTOR signalling pathway. Nat. Rev. Microbiol. 6:266-275.
12. Buchsbaum, R. J., B. A. Connolly, and L. A Feig. 2003. Regulation of p70 S6 kinase by complex formation between the Rac guanine nucleotide exchange factor (Rac-GEF) Tiam1 and the scaffold spinophilin. J. Biol. Chem. 278: 18833-18841.
13. Burnett, P. E., S. Blackshaw, M. M. Lai, I. A. Qureshi, A. F. Burnett, D. M. Sabatini, and S. H. Snyder. 1998. Neurabin is a synaptic protein linking p70 S6 kinase and the neuronal cytoskeleton. Proc. Natl. Acad. Sci. USA 95: 8351-8356.
14. Burstein, E. S., D. J. Hesterberg, J. S. Gutkind, M. R. Brann, E. A. Currier, and T. L. Messier. 1998. The ras-related GTPase rac1 regulates a proliferative pathway selectively utilized by G-protein coupled receptors. Oncogene 17:1617-1623.
15. Cao, G., L. M. Liu, and S. F. Cleary. 1991. Modified method of mammalian cell synchronization improves yield and degree of synchronization. Exp. Cell Res. 193:405-410.
16. Chandrasekaran, B., R. L. Capizzi, T. E. Kute, T. Morgan, and J. Dimling. 1989. Modulation of the metabolism and pharmacokinetics of 1-β-D-arabino-furanosylcytosine by 1-β-D-arabinofuranosyluracil in leukemic mice. Cancer Res. 49:3259-3266.
17. Chou, M. M., and J. Blenis. 1996. The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Racl. Cell 85:573-583.
18. Chung, S. H., R. S. Weiss, K. K. Frese, B. V. Prasad, and R. T. Javier. 2008. Functionally distinct monomers and trimers produced by a viral oncoprotein. Oncogene 27:1412-1420.
19. Corbin-Lickfett, K. A., and E. Bridge. 2003. Adenoviras E4-34kDa requires active proteasomes to promote late gene expression. Virology 315:234-244.
20. Crespo, P., K. E. Schuebel, A. A. Ostrom, J. S. Gutkind, and X. R. Bustelo. 1997. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385:169-172.
21. Datta, S. R., A. Brunet, and M. E. Greenberg. 1999. Cellular survival: a play in three Akts. Genes Dev. 13:2905-2927.
22. Davies, S. P., H. Reddy, M. Caivano, and P. Cohen. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95-105.
23. Deshpande, S. S., P. Angkeow, J. Huang, M. Ozaki, and K. Irani. 2000. Rac1 inhibits TNF-α-induced endothelial cell apoptosis: dual regulation by reactive oxygen species. FASEB J. 14:1705-1714.
24. Evans, J. D., and P. Hearing. 2005. Relocalization of the Mre11-Rad50-Nbs1 complex by the adenovirus E4 ORF3 protein is required for viral replication. J. Virol. 79:6207-6215.
25. Fackler, O. T., W. Luo, M. Geyer, A. S. Alberts, and B. M. Peterlin. 1999. Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. Mol. Cell 3:729-739.
26. Flint, S. J., and R. A. Gonzalez. 2003. Regulation of mRNA production by the adenoviral E1B 55-kDa and E4 Orf6 proteins. Curr. Top. Microbiol. Immunol. 272:287-330.
27. Frese, K. K., S. S. Lee, D. L. Thomas, I. J. Latorre, R. S. Weiss, B. A. Glaunsinger, and R. T. Javier. 2003. Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein. Oncogene 22:710-721.
28. Fruman, D. A., R. E. Meyers, and L. C. Cantley. 1998. Phosphoinositide kinases. Annu. Rev. Biochem. 67:481-507.
29. Gao, Y., J. B. Dickerson, F. Guo, J. Zheng, and Y. Zheng. 2004. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc. Natl. Acad. Sci. USA 101:7618-7623.
30. Garber, K. 2006. China approves world's first oncolytic virus therapy for cancer treatment. J. Natl. Cancer Inst. 98:298-300.
31. Glaunsinger, B. A., S. S. Lee, M. Thomas, L. Banks, and R. Javier. 2000. Interactions of the PDZ-protein MAGI-1 with adenoviras E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene 19:5270-5280.
32. Glaunsinger, B. A., R. S. Weiss, S. S. Lee, and R. Javier. 2001. Link of the unique oncogenic properties of adenoviras type 9 E4-ORF1 to a select interaction with the candidate tumor suppressor protein ZO-2. EMBO J. 20:5578-5586.
33. Goodrum, F. D., and D. A Ornelles. 1998. p53 status does not determine outcome of E1B 55-kilodalton mutant adenovirus lytic infection. J. Virol. 72:9479-9490.
34. Goodrum, F. D., and D. A. Ornelles. 1999. Roles for the E4 orf6, orf3, and E1B 55-kilodalton proteins in cell cycle-independent adenoviras replication. J. Virol. 73:7474-7488.
35. Goodrum, F. D., and D. A, Ornelles. 1997. The early region 1B 55-kilodalton oncoprotein of adenoviras relieves growth restrictions imposed on viral replication by the cell cycle. J. Virol. 71:548-561.
36. Habets, G. G., E. H. Scholtes, D. Zuydgeest, R. A. van der Kammen, J. C. Stam, A. Berns, and J. G. Collard. 1994. Identification of an invasioninducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 77:537-549.
37. Halbert, D. N., J. R. Cutt, and T. Shenk. 1985. Adenoviras early region 4 encodes functions required for efficient DNA replication, late gene expression, and host cell shutoff. J. Virol. 56:250-257.
38. Harada, H., J. S. Andersen, M. Mann, N. Terada, and S. J. Korsmeyer. 2001. p70S6 kinase signals cell survival as well as growth, inactivating the proapoptotic molecule BAD. Proc. Natl. Acad. Sci. USA 98:9666-9670.
39. Harada, J. N., A. Shevchenko, D. C. Pallas, and A. J. Berk. 2002. Analysis of the adenoviras E1B-55K-anchored proteome reveals its link to ubiquitination machinery. J. Virol. 76:9194-9206.
40. Holmes, R. K., M. H. Malim, and K. N. Bishop. 2007. APOBEC-mediated viral restriction: not simply editing? Trends Biochem. Sci. 32:118-128.
41. Izumi, T., K. Shirakawa, and A. Takaori-Kondo. 2008. Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy. Mini-Rev. Med. Chem. 8:231-238.
42. Javier, R. T. 1994. Adenoviras type 9 E4 open reading frame 1 encodes a transforming protein required for the production of mammary tumors in rats. J. Virol. 68:3917-3924.
43. Jeong, H. G., H. J. Cho, I. Y. Chang, S. P. Yoon, Y. J. Jeon, M. H. Chung, and H. J. You. 2002. Racl prevents cisplatin-induced apoptosis through down-regulation of p38 activation in NIH3T3 cells. FEBS Lett. 518:129-134.
44. Jones, N., and T. Shenk. 1979. Isolation of adenoviras type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 17: 683-689.
45. Jones, N., and T. Shenk. 1978. Isolation of deletion and substitution mutants of adenoviras type 5. Cell 13:181-188.
46. Lee, S. S., B. Glaunsinger, F. Mantovani, L. Banks, and R. T. Javier. 2000. Multi-PDZ domain protein MUPP1 is a cellular target for both adenoviras E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins. J. Virol. 74:9680-9693.
47. Li, Z., C. P. Day, J. Y. Yang, W. B. Tsai, G. Lozano, H. M. Shih, and M. C. Hung. 2004. Adenoviral E1A targets Mdm4 to stabilize tumor suppressor p53. Cancer Res. 64:9080-9085.
48. Lowe, S. W., and H. E. Ruley. 1993. Stabilization of the p53 tumor suppressor is induced by adenoviras 5 E1A and accompanies apoptosis. Genes Dev. 7:535-545.
49. Luo, K., E. Ehrlich, Z. Xiao, W. Zhang, G. Ketner, and X.-F. Yu. 2007. Adenoviras E4orf6 assembles with Cullin5-ElonginB-ElonginC E3 ubiquitin ligase through an HIV/SIV Vif-like BC-box to regulate p53. FASEB J. 21:1742-1750.
50. Mertens, A. E., R. C. Roovers, and J. G. Collard. 2003. Regulation of Tiam1-Rac signalling. FEBS Lett. 546:11-16.
51. Moore, M., N. Horikoshi, and T. Shenk. 1996. Oncogenic potential of the adenoviras E4orf6 protein. Proc. Natl. Acad. Sci. USA 93:11295-11301.
52. Nayak, R., K. D. Farris, and D. J. Pintel. 2008. E4Orf6-E1B-55k-dependent degradation of de novo-generated adeno-associated virus type 5 Rep52 and capsid proteins employs a cullin 5-containing E3 ligase complex. J. Virol. 82:3803-3808.
53. Ornelles, D. A., R. N. Broughton-Shepard, and F. D. Goodrum. 2007. Analysis of adenoviras infections in synchronized cells. Methods Mol. Med. 131: 83-101.
54. O'Shea, C., K. Klupsch, S. Choi, B. Bagus, C. Soria, J. Shen, F. McCormick, and D. Stokoe. 2005. Adenoviral proteins mimic nutrient/growth signals to activate the mTOR pathway for viral replication. EMBO J. 24:1211-1221.
55. O'Shea, C. C., S. Choi, F. McCormick, and D. Stokoe. 2005. Adenoviras overrides cellular checkpoints for protein translation. Cell Cycle 4:883-888.
56. Otsuki, Y., M. Tanaka, S. Yoshii, N. Kawazoe, K. Nakaya, and H. Sugimura. 2001. Tumor metastasis suppressor nm23H1 regulates Rac1 GTPase by interaction with Tiam1. Proc. Natl. Acad. Sci. USA 98:4385-4390.
57. Pilder, S., M. Moore, J. Logan, and T. Shenk. 1986. The adenoviras E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol. Cell. Biol. 6:470-476.
58. Post, D. E., F. R. Khuri, J. W. Simons, and E. G. Van Meir. 2003. Replicative oncolytic adenovirases in multimodal cancer regimens. Hum. Gene Ther. 14:933-946.
59. Querido, E., P. Blanchette, Q. Yan, T. Kamura, M. Morrison, D. Boivin, W. G. Kaelin, R. C. Conaway, J. W. Conaway, and P. E. Branton. 2001. Degradation of p53 by adenoviras E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex. Genes Dev. 15: 3104-3117.
60. Querido, E., R. C. Marcellus, A. Lai, R. Charbonneau, J. G. Teodoro, G. Ketner, and P. E. Branton. 1997. Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenoviras-infected cells. J. Virol. 71: 3788-3798.
61. Sarbassov, D. D., S. M. Ali, S. Sengupta, J. H. Sheen, P. P. Hsu, A. F. Bagley, A. L. Markhard, and D. M. Sabatini. 2006. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22:159-168.
62. Sarbassov, D. D., D. A. Guertin, S. M. Ali, and D. M. Sabatini. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307:1098-1101.
63. Schuebel, K. E., N. Movilla, J. L. Rosa, and X. R. Bustelo. 1998. Phosphor-ylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2. EMBO J. 17:6608-6621.
64. Schwartz, R. A, S. S. Lakdawala, H. D. Eshleman, M. R. Russell, C. T. Carson, and M. D. Weitzman. 2008. Distinct requirements of adenoviras Elb55K protein for degradation of cellular substrates. J. Virol. 82:9043-9055.
65. Sheng, M., and C. Sala. 2001. PDZ domains and the organization of supramolecular complexes. Annu. Rev. Neurosci. 24:1-29.
66. Shepard, R. N., and D. A. Ornelles. 2004. Diverse roles for E4orf3 at late times of infection revealed in an E1B 55-kilodalton protein mutant background. J. Virol. 78:9924-9935.
67. Shepard, R. N., and D. A. Ornelles. 2003. E4orf3 is necessary for enhanced S-phase replication of cell cycle-restricted subgroup C adenoviruses. J. Virol. 77:8593-8595.
68. Stracker, T. H., C. T. Carson, and M. D. Weitzman. 2002. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418:348-352.
69. Stracker, T. H., D. V. Lee, C. T. Carson, F. D. Araujo, D. A. Ornelles, and M. D. Weitzman. 2005. Serotype-specific reorganization of the Mre11 complex by adenoviral E4orf3 proteins. J. Virol. 79:6664-6673.
70. Subramanian, C., M. A. Cotter II, and E. S. Robertson. 2001. Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis. Nat. Med. 7:350-355.
71. Sumita, C., M. Yamane, T. Matsuda, M. Maeda, T. Nariai, Y. Fujio, and J. Azuma. 2005. Platelet activating factor induces cytoskeletal reorganization through Rho family pathway in THP-1 macrophages. FEBS Lett. 579:4038-4042.
72. 1 phase restriction point block. J. Clin. Investig. 87:519-527.
73. Ullman, A. J., and P. Hearing. 2008. Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein. J. Virol. 82:7325-7335.
74. Ullman, A, J., N. C. Reich, and P. Hearing. 2007. Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response. J. Virol. 81:4744-4752.
75. Weitzman, M. D., and D. A. Ornelles. 2005. Inactivating intracellular antiviral responses during adenovirus infection. Oncogene 24:7686-7696.
76. Wold, W. S., A. E. Tollefson, and T. W. Hermiston. 1995. E3 transcription unit of adenovirus. Curr. Top. Microbiol. Immunol. 199(Pt. 1):237-274.
77. Woo, J. L., and A. J. Berk. 2007. Adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export. J. Virol. 81:575-587.
78. Wu, H. C., J. T. Hsieh, M. E. Gleave, N. M. Brown, S. Pathak, and L. W. Chung. 1994. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Int. J. Cancer 57:406-412.
79. Yu, W., and H. Fang. 2007. Clinical trials with oncolytic adenovirus in China. Curr. Cancer Drug Targets 7:141-148.